Created at	Source	Raw Value	Validated value
Nov. 26, 2021, 10:30 p.m.	oms	To assess the antiviral efficacy of the investigational products: COVID19 negativity after 7 days of treatmentTimepoint: Baseline; 7 days; 14 days and 28 days	To assess the antiviral efficacy of the investigational products: COVID19 negativity after 7 days of treatmentTimepoint: Baseline; 7 days; 14 days and 28 days
Nov. 13, 2021, 5:33 p.m.	oms	N/A	N/A
Oct. 26, 2020, 8:29 a.m.	oms	To assess the antiviral efficacy of the investigational products: COVID19 negativity after 7 days of treatmentTimepoint: Baseline; 7 days; 14 days and 28 days	To assess the antiviral efficacy of the investigational products: COVID19 negativity after 7 days of treatmentTimepoint: Baseline; 7 days; 14 days and 28 days